Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen Ø, Denmark.
Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Bld 223, 2800, Kgs. Lyngby, Denmark.
Prog Chem Org Nat Prod. 2021;115:59-114. doi: 10.1007/978-3-030-64853-4_2.
Thapsigargin, the first representative of the hexaoxygenated guaianolides, was isolated 40 years ago in order to understand the skin-irritant principles of the resin of the umbelliferous plant Thapsia garganica. The pronounced cytotoxicity of thapsigargin is caused by highly selective inhibition of the intracellular sarco-endoplasmic Ca-ATPase (SERCA) situated on the membrane of the endo- or sarcoplasmic reticulum. Thapsigargin is selective to the SERCA pump and to a minor extent the secretory pathway Ca/Mn ATPase (SPCA) pump. Thapsigargin has become a tool for investigation of the importance of SERCA in intracellular calcium homeostasis. In addition, complex formation of thapsigargin with SERCA has enabled crystallization and structure determination of calcium-free states by X-ray crystallography. These results led to descriptions of the mechanism of action and kinetic properties of SERCA and other ATPases. Inhibition of SERCA depletes Ca from the sarco- and endoplasmic reticulum provoking the unfolded protein response, and thereby has enabled new studies on the mechanism of cell death. Development of protocols for selective transformation of thapsigargin disclosed the chemistry and facilitated total synthesis of the molecule. Conversion of trilobolide into thapsigargin offered an economically feasible sustainable source of thapsigargin, which enables a future drug production. Principles for prodrug development were used by conjugating a payload derived from thapsigargin with a hydrophilic peptide selectively cleaved by proteases in the tumor. Mipsagargin was developed in order to obtain a drug for treatment of cancer diseases characterized by the presence of prostate specific membrane antigen (PSMA) in the neovascular tissue of the tumors. Even though mipsagargin showed interesting clinical effects the results did not encourage funding and consequently the attempt to register the drug has been abandoned. In spite of this disappointing fact, the research performed to develop the drug has resulted in important scientific discoveries concerning the chemistry, biosynthesis and biochemistry of sesquiterpene lactones, the mechanism of action of ATPases including SERCA, mechanisms for cell death caused by the unfolded protein response, and the use of prodrugs for cancer-targeting cytotoxins. The presence of toxins in only some species belonging to Thapsia also led to a major revision of the taxonomy of the genus.
唐松草苦苷是第一个六氧化倍半萜类化合物,于 40 年前被分离出来,目的是为了了解伞形科唐松草属植物树脂的皮肤刺激性原理。唐松草苦苷具有强烈的细胞毒性,这是由于其对位于内质网或肌质网膜上的细胞内肌浆-内质网 Ca-ATP 酶(SERCA)具有高度选择性抑制作用。唐松草苦苷对 SERCA 泵具有选择性,对分泌途径 Ca/Mn ATP 酶(SPCA)泵有一定的选择性。唐松草苦苷已成为研究 SERCA 在细胞内钙稳态中的重要性的工具。此外,唐松草苦苷与 SERCA 形成复合物,使无钙状态的 SERCA 通过 X 射线晶体学进行结晶和结构测定成为可能。这些结果导致了 SERCA 和其他 ATP 酶的作用机制和动力学特性的描述。SERCA 的抑制作用会使肌浆网和内质网中的 Ca 耗竭,引发未折叠蛋白反应,从而使细胞死亡机制的新研究成为可能。选择性转化唐松草苦苷的方案的开发揭示了其化学性质,并促进了该分子的全合成。三尖杉内酯转化为唐松草苦苷为唐松草苦苷提供了一种经济可行的可持续来源,这为未来的药物生产铺平了道路。前药开发原则用于将源自唐松草苦苷的有效载荷与在肿瘤中被蛋白酶选择性切割的亲水肽连接。米普沙格雷因的开发目的是为了获得一种治疗以前列腺特异性膜抗原(PSMA)在肿瘤新生血管组织中存在为特征的癌症疾病的药物。尽管米普沙格雷因显示出有趣的临床效果,但结果并未鼓励资金投入,因此放弃了注册该药物的尝试。尽管这一令人失望的事实,但为开发该药物而进行的研究导致了有关倍半萜内酯的化学、生物合成和生物化学、ATP 酶(包括 SERCA)的作用机制、未折叠蛋白反应引起的细胞死亡机制以及用于癌症靶向细胞毒素的前药的重要科学发现。毒素仅存在于唐松草属的一些物种中,这也导致了该属的分类学的重大修订。